Maynard Um
-
-
-
-
-
-
-
Tvardi Therapeutics (TVRD) Misses Q1 EPS by 73c
-
-
-
-
-
-
-
Tvardi Therapeutics (TVRD) Misses Q3 EPS by 59c
-
-
-
-
-
-
-
Barclays Starts Tvardi Therapeutics Inc (TVRD) at Overweight
-
-
-
-
-
-
-
BTIG Starts Tvardi Therapeutics Inc (TVRD) at Buy
-
448,257 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

